|
C6ORF167 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9549000024609E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06069999952874E-07 |
| Normal-vs-Stage2 |
5.018600E-03 |
| Normal-vs-Stage3 |
6.37709999999903E-05 |
| Normal-vs-Stage4 |
1.041250E-04 |
| Stage1-vs-Stage2 |
9.904200E-01 |
| Stage1-vs-Stage3 |
3.846200E-01 |
| Stage1-vs-Stage4 |
7.879200E-01 |
| Stage2-vs-Stage3 |
6.455600E-01 |
| Stage2-vs-Stage4 |
8.702200E-01 |
| Stage3-vs-Stage4 |
3.986200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.8608000413044E-09 |
| Normal-vs-AfricanAmerican |
7.593800E-01 |
| Normal-vs-Asian |
9.079600E-03 |
| Caucasian-vs-AfricanAmerican |
2.97499999968309E-07 |
| Caucasian-vs-Asian |
7.892800E-01 |
| AfricanAmerican-vs-Asian |
1.525810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07390000003704E-07 |
| Normal-vs-Female |
1.56460000000358E-06 |
| Male-vs-Female |
9.554800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.120200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.90570000177826E-08 |
| Normal-vs-Age(61-80Yrs) |
2.08970000004083E-06 |
| Normal-vs-Age(81-100Yrs) |
2.404100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.963600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.516400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.596800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.367360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.046400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.248200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.600600E-03 |
| Normal-vs-Grade 2 |
1.87730000433817E-08 |
| Normal-vs-Grade 3 |
2.18889999999972E-05 |
| Normal-vs-Grade 4 |
3.720500E-03 |
| Grade 1-vs-Grade 2 |
9.090600E-01 |
| Grade 1-vs-Grade 3 |
4.770000E-01 |
| Grade 1-vs-Grade 4 |
6.849800E-01 |
| Grade 2-vs-Grade 3 |
5.985700E-02 |
| Grade 2-vs-Grade 4 |
4.676200E-01 |
| Grade 3-vs-Grade 4 |
7.086400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.37170053093882E-10 |
| Normal-vs-ccB subtype |
1.553140E-04 |
| ccA subtype-vs-ccB subtype |
7.234800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91300000285111E-08 |
| Normal-vs-N1 |
1.083800E-01 |
| N0-vs-N1 |
6.562600E-01 |
|
|
